Dermatitis medicamentosa resulting from administration of sulfocyanates in the treatment of hypertension

被引:7
作者
Baker, TW [1 ]
Brunsting, LA [1 ]
机构
[1] Mayo Clin, Sect Dermatol, Rochester, MN USA
关键词
D O I
10.1001/jama.1937.92780070002010a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:549 / 550
页数:2
相关论文
共 15 条
[1]  
AYMAN D, 1929, JAMA-J AM MED ASSOC, V93, P1671
[2]  
Barker MH, 1936, J AMER MED ASSOC, V106, P762
[3]  
Bernard C, 1857, LECONS EFFETS SUBSTA
[4]  
BORG JF, 1930, MINN MED, V13, P293
[5]   Observations on thiocyanate therapy in hypertension [J].
Egloff, WC ;
Hoyt, LH ;
O'Hare, JP .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1931, 96 :1941-1942
[6]   The incidence and management of hypertension - With a note on sulphocyanate therapy [J].
Gager, LT .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1928, 90 :82-86
[7]   Thiocyanate therapy in hypertension I. Observations on its toxic effects [J].
Goldring, W ;
Chasis, H .
ARCHIVES OF INTERNAL MEDICINE, 1932, 49 (02) :321-329
[8]   Therapeutics and toxicology of the sulphocyanates [J].
Healy, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1931, 205 :581-583
[9]  
LOGEFEIL RC, 1929, MINN MED, V12, P151
[10]  
Nichols JB, 1925, AM J MED SCI, V170, P735